Belgium (BE)

Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND) (2020) Vera G, Sorlin A, Delplancq G, Lecoquierre F, Brasseur-Daudruy M, Petit F, Smol T, et al. Journal article Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation–An Analysis of 2 German Transplantation Centers (2020) Wolff D, Bardak J, Edinger M, Klinger-Schindler U, Holler E, Lawitschka A, Schoemans H, et al. Journal article Analysis of sequence-defined oligomers through Advanced Polymer Chromatography™ - mass spectrometry hyphenation (2020) Berg MT, Mertens C, Du Prez F, Kühne TD, Herberg A, Kuckling D Journal article Promotion of mental health in young adults via mobile phone app: Study protocol of the ECoWeB (emotional competence for well-being in Young adults) cohort multiple randomised trials (2020) Newbold A, Warren FC, Taylor RS, Hulme C, Burnett S, Aas B, Botella C, et al. Journal article The role of Ti and TiC nanoprecipitates in radiation resistant austenitic steel: A nanoscale study (2020) Cautaerts N, Delville R, Stergar E, Pakarinen J, Verwerft M, Yang Y, Hofer C, et al. Journal article Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function (2020) Wuyts WA, Azuma A, Distler J, Sondergaard K, Proudman S, Cottin V, Erhardt E, et al. Conference contribution Do surgical skills affect outcomes? (2020) Tou S, Gomez Ruiz M, Gallagher AG, Eardley NJ, Matzel K Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results (2020) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution